184
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
273
Ross-Lee L, Heazlewood V, Tyrer JH, Eadie MJ. Aspirin treatment of migraine attacks:
plasma drug level data. Cephalalgia. 1982 Mar;2(1):9-14.
274
Rote Liste online: Dociton®, Stand Dezember 2013
275
Rozen TD, Fishman RS. Demand valve oxygen: a promising new oxygen delivery system
for the acute treatment of cluster headache. Pain Med. 2013 Apr;14(4):455-9.
276
Rozen TD, Fishman RS. Inhaled oxygen and cluster headache sufferers in the United Sta-
tes: use, efficacy and economics: results from the United States Cluster Headache Survey.
Headache. 2011 Feb;51(2):191-200.
277
Rozen TD. Inhaled Oxygen for Cluster Headache: Efficacy, Mechanism of Action, Utilizati-
on, and Economics. Curr Pain Headache Rep. 2012 Jan 29.
278
Rozen TD. Migraine Headache: Immunosuppressant Therapy. Curr Treat Options Neurol.
2002 Sep;4(5):395-401.
279
Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol. 2004
May;3(5):279-83. Review.
280
Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine: a
review of prospective studies and retrospective analyses. Cephalalgia. 1999 Jan;19(1):16-
9. Review.
281
Sances G, Galli F, Ghiotto N, Allena M, Guaschino E, Frustaci A, Nappi G, Tassorelli C.
Factors associated with a negative outcome of medication-overuse headache: a 3-year
follow-up (the 'CARE' protocol). Cephalalgia. 2013 May;33(7):431-43.
282
Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, Nappi G. Risk factors in
medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia.
2010 Mar;30(3):329-36.
283
Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium
in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache.
1990 Nov;30(11):705-9.
284
Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients
suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg.
1997 Dec;87(6):876-80.
285
Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G. Botulinum
toxin type-A in the prophylactic treatment of medication-overuse headache: a multicen-
ter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain.
2011 Aug;12(4):427-33.
286
Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ; ONSTIM Inves-
tigators. Occipital nerve stimulation for the treatment of intractable chronic migraine
headache: ONSTIM feasibility study. Cephalalgia. 2011 Feb;31(3):271-85.
287
Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR. Chronic daily headache prophy-
laxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
Headache. 2002 Jun;42(6):470-82.